DekaBank Deutsche Girozentrale - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$37,000
-37.3%
13,0000.0%0.00%
Q2 2021$59,000
-20.3%
13,0000.0%0.00%
Q1 2021$74,000
+10.4%
13,0000.0%0.00%
Q4 2020$67,000
+52.3%
13,0000.0%0.00%
Q3 2020$44,000
-82.5%
13,000
-13.3%
0.00%
-100.0%
Q4 2018$252,00015,0000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 724,202$811,0000.11%
PURA VIDA INVESTMENTS, LLC 1,578,140$1,768,0000.06%
Founders Fund V Management, LLC 491,751$550,0000.04%
XTX Topco Ltd 40,618$45,0000.02%
Caption Management, LLC 725,000$813,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,450$265,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 51,465$58,0000.01%
Virtu Financial LLC 49,959$56,0000.00%
Caption Management, LLC 225,000$252,0000.00%
ACADIAN ASSET MANAGEMENT LLC 389,893$435,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders